MedTrace Logo

Pharmacists Intervention to Improve Hypertension Management in Primary Care

NCT03274531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 497

Last updated 2020-04-07

No results posted yet for this study

Summary

Arterial hypertension is the single largest contributor to mortality world-wide, and only 30-50% of diagnosed and treated patients achieve their blood pressure goal. The APOTHECARE trial is designed to identify treated patients with uncontrolled hypertension in community pharmacies in order to improve blood pressure control through intensification of antihypertensive therapy.

Conditions

Interventions

BEHAVIORAL

Referral of hypertensive patients to the attending physician

Immediate referral to the treating physician in case of elevated automated office blood pressure measurements

Sponsors & Collaborators

  • Österreichische Apothekerkammer, Landesgeschäftsstelle Niederösterreich

    collaborator UNKNOWN

  • Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology

    collaborator OTHER

  • Institute for Cardiometabolic Diseases, Karl Landsteiner Society

    collaborator UNKNOWN

  • Wilhelminenspital Vienna

    lead OTHER

Principal Investigators

  • Miklos Rohla, MD · 3rd Medical Department, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria

  • Thomas W Weiss, MD, PhD · 3rd Medical Department, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-16
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03274531 on ClinicalTrials.gov